This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Debio 1143 plus chemoradiotherapy improved head and neck squamous cell carcinoma disease control.
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
October 2020
Volume 10, Issue 10
Volume 10, Issue 10
The IAP Antagonist Debio 1143 Enhances Chemoradiotherapy in HNSCC
Jump to section
Advertisement